These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2476590)

  • 1. Electrophysiologic, antiarrhythmic, and cardioprotective effects of N-[3,5 dichlorophenyl] 4-[4-hydroxy-2-methoxy-phenyl] piperazine carboxamidine dihydrochloride (RS-87337).
    Dumez D; Patmore L; Ferrandon P; Allely M; Armstrong JM
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):184-93. PubMed ID: 2476590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-independent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I anti-arrhythmics.
    Mestre M; Djellas Y; Carriot T; Cavero I
    Fundam Clin Pharmacol; 2000; 14(2):107-17. PubMed ID: 10796057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel class Ia and class III antiarrhythmic agent RS-87337 on myocardial conduction in the anaesthetised dog.
    Allely MC; Alps BJ
    Arch Int Pharmacodyn Ther; 1988; 295():138-46. PubMed ID: 3245729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.
    Allan G; Donoghue S; Follenfant MJ; Sawyer DA
    Br J Pharmacol; 1986 Jun; 88(2):333-43. PubMed ID: 3730698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.
    Boachie-Ansah G; Sitsapesan R; Kane KA; Parratt JR
    Br J Pharmacol; 1989 Jul; 97(3):801-8. PubMed ID: 2758241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
    Barron E; Marshall RJ; Martorana M; Winslow E
    Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.
    Toyama J; Kodama I; Honjo H; Kamiya K
    Br J Pharmacol; 1989 Sep; 98(1):177-85. PubMed ID: 2553186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics.
    Johnston KM; MacLeod BA; Walker MJ
    Can J Physiol Pharmacol; 1983 Nov; 61(11):1340-53. PubMed ID: 6661688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of RS-2135, a novel class I antiarrhythmic agent, on sustained ventricular tachycardia after coronary embolization in conscious dogs.
    Yorikane R; Mizuno H; Itoh Y; Miyake S; Koike H
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):28-36. PubMed ID: 7521486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
    Wu B; Sato T; Kiyosue T; Arita M
    Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of capsaicin: antiarrhythmic and antiischemic activity.
    D'Alonzo AJ; Grover GJ; Darbenzio RB; Hess TA; Sleph PG; Dzwonczyk S; Zhu JL; Sewter JC
    Eur J Pharmacol; 1995 Jan; 272(2-3):269-78. PubMed ID: 7713171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
    Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
    Dong H; Sheng JZ; Lee CM; Wong TM
    Br J Pharmacol; 1993 May; 109(1):113-9. PubMed ID: 8495235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs.
    Grover GJ; Sleph PG; Dzwonczyk S
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):853-64. PubMed ID: 1704976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological and mechanical effects of caffeic acid phenethyl ester, a novel cardioprotective agent with antiarrhythmic activity, in guinea-pig heart.
    Chang GJ; Chang CJ; Chen WJ; Yeh YH; Lee HY
    Eur J Pharmacol; 2013 Feb; 702(1-3):194-207. PubMed ID: 23396228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and interpretation of voltage- and frequency-dependent electrophysiologic effects of a new class I antiarrhythmic agent (nicainoprol) on guinea pig papillary muscle and isolated heart.
    Weirich J; Antoni H
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):664-71. PubMed ID: 2467084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.